Plasma derivatives are manufactured from human plasma donations in plasma fractionation centers such as albumin, coagulation factors, and immunoglobulins. These are licensed medicinal products. These products are manufactured from large donor pools, sometimes thousands of donations, all now undergo multiple pathogen inactivation steps to eradicate transfusion-transmitted viruses. Since 1999, all plasma derivatives used in the UK are derived from imported plasma. The Medicines Act covers plasma derivatives and, like any other drug, must be prescribed by a licensed practitioner.
MARKET DYNAMICS
Factors driving the growth of the blood derivative product market are the growing prevalence of life-threatening disorders, especially hemophilia. However, the high cost of plasma derivative-based therapy is expected to hamper the growth of the market.
Moreover, the rise in the adoption of blood plasma derivatives products and growing awareness about blood & plasma donation is anticipated to drive demand for blood derivative product systems to boost the market growth.
MARKET SCOPE
The "Blood Derivative Product Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of blood derivative product market with detailed market segmentation by type and application. The blood derivative product market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in blood derivative product market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The blood derivative product market is segmented on the basis of type and application. Based on type, the market is broadly segmented as albumin, coagulation factor concentrates, immunoglobulins, and others. On the basis of application, the market is categorized as platelet aggregation inhibitors, fibrinolytics, anticoagulants, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the blood derivative product market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The blood derivative product market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting blood derivative product market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the blood derivative product market in these regions.
MARKET PLAYERS
The report covers key developments in the blood derivative product market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from blood derivative product market are anticipated to have lucrative growth opportunities in the future with the rising demand for blood derivative product in the global market. Below mentioned is the list of few companies engaged in the blood derivative product market.
The report also includes the profiles of key players in blood derivative product market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GlaxoSmithKline plc
- Pfizer, Inc.
- Bristol-Myers Squibb Company
- Leo Pharma A/S
- Sanofi
- Xiamen Hisunny Chemical Co., LTD
- AstraZeneca
- Baxter
- Grifols S.A.
- CSL Behring
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.